Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets
NEW DELHI: Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10...
Zydus Cadila
Zydus Cadila, Taiwan’s TLC ink pact to market black fungus drug in India
NEW DELHI: Zydus Cadila and Taiwan-based specialty pharmaceutical firm TLC on Wednesday said they have signed a pact to market...
Zydus Cadila receives final approval from USFDA for Droxidopa Capsules
NEW DELHI: Zydus Cadila has received final approval from the USFDA to market Droxidopa Capsules, 100 mg, 200 mg, and...
Zydus Cadila announces completion of phase-I trials of malaria drug
NEW DELHI: Ahmedabad-based Zydus Cadila Healthcare has announced that its antimalarial compound ZY19489 (MMV253) in development with Swiss-based product development...
